HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel R Hostetter Selected Research

procathepsin E

1/2016Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel R Hostetter Research Topics

Disease

5Neoplasms (Cancer)
04/2019 - 08/2010
2Neoplasm Metastasis (Metastasis)
04/2019 - 08/2010
2Prostatic Neoplasms (Prostate Cancer)
04/2015 - 06/2012
1Adenocarcinoma
01/2016
1Disease Progression
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2012
1Inflammation (Inflammations)
08/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2010

Drug/Important Bio-Agent (IBA)

4Peptide Hydrolases (Proteases)FDA Link
04/2019 - 08/2011
2Granzymes (Granzyme)IBA
06/2012 - 08/2011
1ProdrugsIBA
04/2019
1procathepsin EIBA
01/2016
1CathepsinsIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Ritonavir (Norvir)FDA Link
01/2016
1Cathepsin EIBA
01/2016
1Aspartic Acid ProteasesIBA
01/2016
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2015
1Plasminogen Activators (Plasminogen Activator)IBA
04/2015
1Immunoglobulin G (IgG)IBA
04/2015
1Immunoglobulins (Immunoglobulin)IBA
04/2015
1Radioisotopes (Radionuclides)IBA
04/2015
1Cetuximab (Erbitux)FDA Link
10/2013
1Protease Inhibitors (Protease Inhibitor)IBA
11/2012
1AntibodiesIBA
08/2010
1Urokinase Plasminogen Activator ReceptorsIBA
08/2010
1LigandsIBA
08/2010